Your browser doesn't support javascript.
loading
Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
Kostantinis, Spyridon; Rempakos, Athanasios; Simsek, Bahadir; Karacsonyi, Judit; Allana, Salman S; Alaswad, Khaldoon; Basir, Mir B; Krestyaninov, Oleg; Khelimskii, Dmitrii; Gorgulu, Sevket; Davies, Rhian E; Benton, Stewart M; Khatri, Jaikirshan J; Poommipanit, Paul; Choi, James W; Jaber, Wissam A; Rinfret, Stephane; Nicholson, William; Al-Azizi, Karim M; Potluri, Srinivasa; Aygul, Nazif; Altunkeser, Bulent B; Koutouzis, Michael; Tsiafoutis, Ioannis; Milkas, Anastasios; ElGuindy, Ahmed M; Abi Rafeh, Nidal; Goktekin, Omer; Mastrodemos, Olga C; Rangan, Bavana V; Sandoval, Yader; Burke, M Nicholas; Brilakis, Emmanouil S.
Afiliação
  • Kostantinis S; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Rempakos A; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Simsek B; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Karacsonyi J; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Allana SS; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Alaswad K; Department of Cardiology, Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
  • Basir MB; Department of Cardiology, Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
  • Krestyaninov O; Department of Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.
  • Khelimskii D; Department of Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.
  • Gorgulu S; Department of Cardiology, Biruni University Medical School, Istanbul, Turkey.
  • Davies RE; Department of Cardiology, Wellspan York Hospital, York, Pennsylvania, USA.
  • Benton SM; Department of Cardiology, Wellspan York Hospital, York, Pennsylvania, USA.
  • Khatri JJ; Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Poommipanit P; Department of Cardiology, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
  • Choi JW; Department of Cardiology, Texas Health Presbyterian Hospital, Dallas, Texas, USA.
  • Jaber WA; Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
  • Rinfret S; Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
  • Nicholson W; Department of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
  • Al-Azizi KM; Department of Cardiology, The Heart Hospital - Plano, Plano, Texas, USA.
  • Potluri S; Department of Cardiology, The Heart Hospital - Plano, Plano, Texas, USA.
  • Aygul N; Department of Cardiology, Selcuk University Medical Faculty, Konya, Turkey.
  • Altunkeser BB; Department of Cardiology, Selcuk University Medical Faculty, Konya, Turkey.
  • Koutouzis M; Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.
  • Tsiafoutis I; Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.
  • Milkas A; Department of Cardiology, Athens Naval and Veterans Hospital, Athens, Greece.
  • ElGuindy AM; Department of Cardiology, Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt.
  • Abi Rafeh N; Department of Cardiology, North Oaks Health System, Hammond, Los Angeles, USA.
  • Goktekin O; Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey.
  • Mastrodemos OC; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Rangan BV; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Sandoval Y; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Burke MN; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Brilakis ES; Department of Cardiology, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
Catheter Cardiovasc Interv ; 102(4): 585-593, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37560823
ABSTRACT

BACKGROUND:

Donor vessel injury is a potentially life-threatening complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

AIMS:

Our goal was to examine the incidence, mechanisms, treatment, and outcomes of patients with donor vessel injury in a large multicenter CTO PCI registry.

METHODS:

We analyzed the baseline clinical and angiographic characteristics, and procedural outcomes of 12,349 CTO PCIs performed between 2012 and 2022 at 44 centers.

RESULTS:

The incidence of donor vessel injury was 0.35% (n = 43). The baseline clinical characteristics of patients with and without donor vessel injury were similar. Cases complicated by donor vessel injury were more complex with higher Japanese CTO score (2.9 ± 1.1 vs. 2.4 ± 1.3; p = 0.004) and lower procedural success rate (69.8% vs. 85.2%; p = 0.004). The retrograde approach was used more commonly in donor vessel injury cases (68.9% vs. 30.9%; p < 0.001). Most (53.5%) donor vessel injuries were guide catheter-induced, whereas 20.9% were due to donor vessel thrombosis. Of the 43 patients with donor vessel injury, 36 (83.7%) were treated with stenting and seven (16.3%) received a left ventricular assist device. The incidence of major adverse cardiovascular events (MACEs) was significantly higher in cases with donor vessel injury (23.3% vs. 2.0%; p < 0.001). Of the 43 patients with donor vessel injury, five patients (11.6%) experienced acute myocardial infarction and four patients (9.3%) died.

CONCLUSIONS:

Donor vessel injury, occurred in 0.35% of CTO PCIs performed by experienced operators, was mainly due to guide catheter-induced dissection or thrombosis and was associated with lower procedural success and higher MACE.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos